For firms litigating GLP-1 claims, the ruling may affect case valuation, injury screening, discovery strategy, expert planning, and the range of claims that survive into later phases of the MDL
Discard it after use
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced [PMID: 21295044] Laboratory literature summary: Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions
This positions copper peptide as relatively safe for breaks, cycling, or discontinuation compared to more aggressive treatments requiring continuous use for maintaining results or risking rebound worsening
For weight management, these medications should be prescribed within specialist weight management services
When whole-food protein intake is consistently suppressed by GLP-1 therapy, a free-form EAA supplement can help maintain EAA availability without the caloric load or digestive demand of a full protein shake